NFKB1 and neoplasm: F nucleatum can activate NF-κB-driven inflammatory responses to promote tumor progression.[22,23] Additionally, the enterotoxin (Bft) also activates the MAPK pathway, enhances NF-κB signaling, and triggers mucosal inflammation response in intestinal epithelial cells.[24–27]